Page last updated: 2024-10-31

clorgyline and Glioblastoma

clorgyline has been researched along with Glioblastoma in 1 studies

Clorgyline: An antidepressive agent and monoamine oxidase inhibitor related to PARGYLINE.
clorgyline : An aromatic ether that is the 2,4-dichlorophenyl ether of 3-aminopropan-1-ol in which the nitrogen is substituted by a methyl group and a prop-1-yn-3-yl group. A monoamine oxidase inhibitor, it was formerly used as an antidepressant.

Glioblastoma: A malignant form of astrocytoma histologically characterized by pleomorphism of cells, nuclear atypia, microhemorrhage, and necrosis. They may arise in any region of the central nervous system, with a predilection for the cerebral hemispheres, basal ganglia, and commissural pathways. Clinical presentation most frequently occurs in the fifth or sixth decade of life with focal neurologic signs or seizures.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Tseng, HJ1
Banerjee, S1
Qian, B1
Lai, MJ1
Wu, TY1
Hsu, TI1
Lin, TE1
Hsu, KC1
Chuang, KH1
Liou, JP1
Shih, JC1

Other Studies

1 other study available for clorgyline and Glioblastoma

ArticleYear
Design, synthesis, and biological activity of dual monoamine oxidase A and heat shock protein 90 inhibitors, N-Methylpropargylamine-conjugated 4-isopropylresorcinol for glioblastoma.
    European journal of medicinal chemistry, 2023, Aug-05, Volume: 256

    Topics: Animals; Antineoplastic Agents; Clorgyline; Glioblastoma; HSP70 Heat-Shock Proteins; HSP90 Heat-Shoc

2023